Meticulous Research®, a premier market research company, has released a new report titled,   Artificial Intelligence in Genomics Market   by Offering (Software, Services), Functionality (Sequencing, Gene Editing), Application (Diagnostics, Precision Medicine, Drug Discovery and Development), Delivery Mode (On-premises, Cloud) and End User—Global Forecast to 2029.

Market Growth Projections

The AI in genomics market is expected to grow at an extraordinary compound annual growth rate (CAGR) of 42.8% during the forecast period from 2022 to 2029, reaching $6.22 billion by 2029. The rapid integration of AI in genomics, increasing investments in genomic research, and the growing demand for faster drug discovery processes are driving this substantial growth. The rising use of machine learning (ML) in precision medicine and the emergence of startups specializing in AI and genomics are further creating new opportunities in this market.

Download Sample Copy Here:  https://www.meticulousresearch.com/download-sample-report/cp_id=5345 

Detailed Market Segmentation

This research divides the AI in genomics market into various segments, including offering (software, services), delivery mode (on-premises, cloud/web-based), functionality (genome sequencing, gene editing), application (drug discovery, diagnostics, precision medicine), and end-users (pharmaceutical companies, academic institutes). It also evaluates market leaders and their regional presence.

Software as a Key Market Driver

By 2022, the software segment is anticipated to hold the largest share of the market. Software products, often sold through subscription or licensing models, generate significant recurring revenue. Moreover, continued technological advancements in AI are enhancing genomics software, which is expected to fuel further market growth.

Cloud-based Solutions on the Rise

Cloud and web-based delivery modes are expected to experience the fastest growth, offering cost-saving benefits, flexibility, automatic software updates, and better data security, which makes them increasingly popular among pharmaceutical companies.

Genome Sequencing Dominates Functionality

Genome sequencing is projected to lead the functionality category by 2022, as AI helps analyze large genetic datasets more efficiently, accelerating disease gene identification and making it essential for drug discovery.

AI's Impact on Drug Discovery and Development

The drug discovery and development application segment is forecasted to hold the largest market share in 2022. AI’s ability to optimize drug discovery by modeling diseases, identifying targets, and optimizing drug candidates more cost-effectively and efficiently is revolutionizing the industry.

Pharmaceutical Sector Driving AI Adoption

Pharmaceutical and biopharmaceutical companies are predicted to be the largest end-users of AI in genomics by 2022. AI-powered genomics solutions enable these companies to enhance drug discovery processes, lower costs, and improve the development of precision medicine.

Regional Market Insights: North America Leads

North America is expected to dominate the global AI in genomics market, followed by Europe and the Asia-Pacific. The United States is set to hold the largest share of the market in North America due to strong investment in genomics and the growing implementation of AI in healthcare.

Key Players

The key players operating in the global AI in genomics market are Microsoft Corporation (U.S.), NVIDIA Corporation (U.S.), Deep Genomics Incorporated (Canada), Fabric Genomics, Inc. (U.S.), Data4Cure, Inc. (U.S.), Predictive Oncology Inc. (U.S.), Emedgene Technologies LTD (U.S.), Congenica Ltd. (U.K.), Tempus Labs, Inc. (U.S.), SOPHiA GENETICS SA (Switzerland), Illumina Inc. (U.S.), and BenevolentAI Limited. (U.K.).

Buy Now :   https://www.meticulousresearch.com/Checkout/40485578

Key questions answered in the report-

• Which are the high-growth market segments in terms of offering, delivery mode, functionality, application, end user, and geography?
• What was the historical market for AI in genomics across the globe?
• What are the market forecasts and estimates for the period 2022–2029?
• What are the major drivers, restraints, opportunities, and challenges in the global AI in genomics market?
• Who are the major players in the global Artificial Intelligence in genomics market?
• How is the competitive landscape, and who are the market leaders in the global AI in genomics market?
• What are the recent developments in the AI in genomics market?
• What are the different strategies adopted by the major players in the AI in genomics market?
• What are the geographic trends and high growth regions/countries?

Browse in Depth :   https://www.meticulousresearch.com/product/ai-in-genomics-market-5345

Contact Us:
Meticulous Research®
Email-  sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn-  https://www.linkedin.com/company/meticulous-research

Meticulous Research®, a prominent market research organization, has released an insightful report titled “ Asia-Pacific DTC Laboratory Testing Market   by Application (Genetic Testing {Ancestry, Disease Risk [Cancer, Cardiac, Neurological], Carrier Status}, Diabetes, COVID, Routine, Thyroid), and Sample Type (Blood, Saliva, Urine) – Forecast to 2030.” This report sheds light on the impressive growth potential of the direct-to-consumer (DTC) laboratory testing market in the Asia-Pacific region.

According to the findings, the Asia-Pacific DTC laboratory testing market is expected to surge to an   impressive $1.58 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.8% from 2024 to 2030 . Several factors are driving this upward trend. Among them are the rising prevalence of chronic diseases such as diabetes and cardiovascular conditions, increased awareness of personal health management, and the growing trend of consumers seeking easy and accessible laboratory testing options. The affordability and convenience offered by DTC tests are attracting a wider consumer base, particularly as healthcare costs continue to climb across the region.

Download Sample Report Here @  https://www.meticulousresearch.com/download-sample-report/cp_id=5673

Further fueling the growth of this market is the increasing elderly population, which faces a higher incidence of chronic diseases and thus, requires frequent monitoring and testing. The rising penetration of telehealth services, especially in remote or underserved areas, also presents new opportunities for the expansion of the DTC laboratory testing market. Additionally, pharmacogenomic testing, which analyzes how genes affect a person’s response to drugs, is rapidly becoming a key area of interest within the DTC testing space, driving further market expansion.

Despite the positive outlook, the Asia-Pacific DTC laboratory testing market does face some challenges. Concerns over the privacy of genetic data, the risk of misinterpreting test results, and the lack of professional medical counseling accompanying DTC tests may limit their adoption. Furthermore, issues such as regulatory hurdles, concerns about sample integrity, and the limited range of tests compared to conventional laboratory testing are restraining market growth to some extent.

The market is segmented based on application and sample type .

  Applications   include genetic testing, diabetes testing, routine clinical testing, thyroid function testing, and testing for sexually transmitted diseases (STDs). Genetic testing, in particular, is expected to dominate the market in 2024, driven by the increasing curiosity of consumers about their ancestry and the growing availability of disease risk assessment tests.

In terms of sample types , blood samples are anticipated to account for the largest market share, due to the variety of tests available using blood samples, the reliability of results, and the convenience of at-home blood collection services. Additionally, the high prevalence of chronic diseases in the region is prompting consumers to monitor their health more closely, further supporting the demand for blood-based testing.

The report also provides   a geographic review , analyzing key markets within the Asia-Pacific region, including China, Japan, India, Australia, and South Korea, among others. China is expected to dominate the regional market in 2024, primarily due to its large population, rising disposable income levels, and increasing awareness regarding personal health monitoring.

Overall, the Asia-Pacific DTC laboratory testing market is poised for significant growth, driven by technological advancements, increased consumer awareness, and the rising prevalence of chronic diseases. However, addressing challenges related to privacy, test accuracy, and regulatory concerns will be crucial to maintaining momentum in this rapidly expanding market.

QUICK BUY :   https://www.meticulousresearch.com/Checkout/41991350

Key questions answered in the report:

• Which are the high-growth market segments in terms of Asia Pacific dtc laboratory testing by application, sample, and geography?
• What was the historical market for dtc laboratory testing across Asia-Pacific?
• What are the market forecasts and estimates for the period 2024–2030?
• What are the major drivers, restraints, opportunities, and challenges in the Asia-Pacific dtc laboratory testing market?
• Who are the major players in the Asia-Pacific dtc laboratory testing market?
• What is the competitive landscape, and who are the market leaders in the Asia-Pacific dtc laboratory testing market?
• What are the recent developments in the Asia-Pacific dtc laboratory testing market?
• What are the different strategies adopted by the major players in the Asia-Pacific dtc laboratory testing market?
• What are the geographical trends and high-growth regions/countries?

Contact Us:
Meticulous Research®
Email-  sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn-  https://www.linkedin.com/company/meticulous-research

Meticulous Research®, a well-regarded market research firm, has released an insightful new study titled,   ‘ U.S. Direct-to-consumer Laboratory Testing Market   by Application (Genetic Testing {Ancestry, Carrier Status, Disease Risk [Cancer, Neurological, Cardiac]}, Diabetes, Thyroid, STD, Routine, CBC), Sample Type (Saliva, Urine, Blood) - Forecast to 2030.’   This comprehensive report provides a detailed analysis of the U.S. direct-to-consumer (DTC) laboratory testing market, underscoring its growth potential and the major trends shaping its trajectory over the coming years.

According to this latest publication from Meticulous Research®, the U.S. direct-to-consumer laboratory testing market is on a rapid upward trajectory. The market is expected to reach a valuation of   $3.91 billion by the year 2030, reflecting a compound annual growth rate (CAGR) of 10.4% from 2024 to 2030 . The report attributes this remarkable growth to several pivotal factors. Foremost among these are the increasing prevalence of chronic diseases, such as diabetes, cardiovascular conditions, and neurological disorders, alongside the rising incidence of sexually transmitted diseases (STDs). These health concerns have led to a greater demand for accessible testing options, driving consumers toward direct-to-consumer testing services.

Download Sample Report Here @  https://www.meticulousresearch.com/download-sample-report/cp_id=5728

One of the most compelling reasons for the growth   of DTC laboratory testing is the heightened awareness of personal health management. Consumers are becoming increasingly proactive about monitoring their health, spurred on by advancements in medical technology and the ease of access to health information online. This trend is further supported by the growing interest in genetic testing, with people seeking insights into their ancestry, carrier status, and potential disease risks, including cancer and neurological conditions. The U.S. market is also benefiting from an aging population, as older adults are more likely to seek routine health testing and predictive testing services to manage their health proactively.

The convenience, affordability, and accessibility of direct-to-consumer testing are major selling points for the market. Traditional laboratory testing often involves multiple steps, such as scheduling appointments, getting referrals, and visiting a medical facility. In contrast, DTC testing allows consumers to bypass many of these steps, offering at-home collection kits and quicker access to test results. This convenience is particularly attractive in a fast-paced society where time is a precious commodity. Additionally, the cost of DTC tests tends to be more affordable compared to conventional laboratory services, making these tests accessible to a broader population.

Telehealth and pharmacogenomic testing are emerging trends in the direct-to-consumer laboratory testing space, offering new growth opportunities. The expansion of telehealth services, which surged during the COVID-19 pandemic, has made it easier for consumers to consult healthcare providers remotely and receive recommendations for DTC tests. Pharmacogenomic testing, which assesses how individuals respond to different medications based on their genetic makeup, is also gaining traction in the DTC space, allowing consumers to take a more personalized approach to their healthcare.

While the U.S. direct-to-consumer laboratory testing market presents numerous growth opportunities, several challenges need to be addressed. One of the primary concerns is the privacy of genetic data. As more consumers submit their genetic information for testing, there is a growing need for stringent privacy regulations to protect this sensitive data from misuse or unauthorized access. Furthermore, the potential for misinterpretation of test results poses a risk. Without professional medical counseling, consumers may struggle to understand their results, leading to unnecessary anxiety or, conversely, a false sense of security.

Another hurdle for the market is the issue of sample integrity. At-home sample collection, while convenient, may sometimes lead to compromised samples, affecting the accuracy of test results. Moreover, regulatory concerns persist in the DTC testing industry, as the lack of consistent guidelines and oversight can result in varying quality across different testing providers. The absence of insurance reimbursement for many DTC tests also limits market growth, as consumers must pay out-of-pocket for services that would otherwise be covered in a traditional healthcare setting.

Despite these challenges, the U.S. direct-to-consumer laboratory testing market is expected to experience robust growth across various applications. The report identifies genetic testing as a key driver of this growth, with the segment expected to hold the largest market share by 2024. The rising demand for DTC genetic testing can be attributed to several factors. For one, consumers are increasingly curious about their ancestry and genealogy, seeking to understand their family health history and potential disease risks. Additionally, the launch of new DTC genetic tests catering to a wide range of health concerns, from cancer risk assessment to neurological disorders, has expanded the appeal of these services.

In terms of sample types , blood testing is anticipated to dominate the market, holding the largest share in 2024. Blood samples offer several advantages in the context of DTC testing, including the reliability of results and the availability of a wide range of test options. Moreover, advancements in at-home blood collection technologies have made it easier for consumers to submit blood samples without visiting a clinic, further contributing to the popularity of this sample type.

In conclusion , the U.S. direct-to-consumer laboratory testing market is positioned for substantial growth over the next several years, driven by a combination of technological advancements, rising consumer awareness, and a growing focus on personalized healthcare. While challenges such as data privacy, regulatory concerns, and sample integrity need to be addressed, the market's potential remains immense, with significant opportunities for innovation and expansion. As more consumers embrace the convenience and accessibility of DTC testing, the industry is likely to play an increasingly important role in the broader healthcare landscape, offering individuals greater control over their health and wellness.

Purchase Now :   https://www.meticulousresearch.com/Checkout/70676185

Key Players

The key players profiled in the U.S. direct-to-consumer laboratory testing market report are Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), EverlyWell, Inc. (U.S.), DirectLabs, LLC (U.S.), Ancestry.com, LLC (U.S.), 23andMe Holding Co. (U.S.), MyMedLab, Inc. (U.S.), ANY LAB TEST NOW (U.S.), LetsGetChecked, Inc. (U.S.), and Myriad Genetics, Inc. (U.S.).

Key questions answered in the report-

• Which are the high-growth market segments in terms of direct-to-consumer laboratory testing by application, sample, and geography?
• What was the historical market for direct-to-consumer laboratory testing across the U.S.?
• What are the market forecasts and estimates for the period 2024–2030?
• What are the major drivers, restraints, opportunities, and challenges in the U.S. direct-to-consumer laboratory testing market?
• Who are the major players in the U.S. direct-to-consumer laboratory testing market?
• What is the competitive landscape, and who are the market leaders in the U.S. direct-to-consumer laboratory testing market?
• What are the recent developments in the U.S. direct-to-consumer laboratory testing market?
• What are the different strategies adopted by the major players in the U.S. direct-to-consumer laboratory testing market?
• What are the geographical trends and high-growth regions/countries?

Contact Us:
Meticulous Research®
Email-  sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn-  https://www.linkedin.com/company/meticulous-research

Meticulous Research®, a renowned global market research company, has released a comprehensive report titled ‘ NORTH AMERICA ELECTRONIC LAB NOTEBOOK MARKET by Product (Cross-disciplinary, Specific), Technology (Proprietary, Open-source), Channel (Web & Cloud-based, On-premise), End User (Pharmaceutical, Biotech, CROs, Academia/ Research, F&B)—Forecast to 2030.’

The report projects that the North American market for electronic lab notebooks (ELNs) will reach $372.7 million by 2030, growing at a compound annual growth rate (CAGR) of 6.8% from 2024 to 2030. Key factors contributing to this growth include the increasing prevalence of R&D activities in the life sciences sector, the rising trend of laboratory automation, and advancements in laboratory informatics. The growing demand for adherence to regulatory frameworks further stimulates market expansion.

Download Sample Report Here @  https://www.meticulousresearch.com/download-sample-report/cp_id=5604

Moreover, the report highlights the expanding role of cloud-based ELNs and the integration of artificial intelligence, which are anticipated to offer substantial growth opportunities for market players in the near future.

However, the report also underscores certain challenges, such as the high costs of transitioning from traditional to electronic lab notebooks and hesitation among laboratories to adopt ELNs. Additionally, the complexities of system integration and data security concerns pose significant obstacles to market growth.

Future Market Outlook

The North America electronic lab notebooks market is categorized by product, technology, channel, end-user, and geography. The study offers a detailed country-level analysis and evaluates the competitive landscape.

Within the product category, cross-disciplinary ELNs are projected to command the largest market share by 2024. Their popularity is driven by their versatility in serving multiple scientific disciplines, reducing IT overheads, and centralizing data storage. Cross-disciplinary ELNs are also valued for improving workflow management and collaboration across diverse research fields.

From a technology perspective, proprietary ELNs are expected to dominate the market due to their customizable features, enhanced support, and ownership advantages.

In terms of distribution, the web & cloud-based ELN segment is anticipated to lead due to its cost-efficiency, real-time analysis capabilities, and ease of integration with existing systems.

Among end users, pharmaceutical companies are forecast to hold the largest market share in 2024. This is attributed to their rapid adoption of digital technologies and laboratory informatics solutions.

Geographic Analysis

The report evaluates the market at the national level within North America, focusing on the U.S. and Canada. In 2024, the U.S. is expected to capture the largest share, driven by the country's robust economy, stringent regulations, and high laboratory automation levels. The U.S. also benefits from the presence of leading ELN vendors and an increasing adoption of cloud-based solutions.

Key Players

The key players operating in the North America electronic lab notebooks market are Abbott Laboratories (U.S.), Agilent Technologies, Inc. (U.S.), Arxspan, LLC (U.S.), Benchling, Inc. (U.S.), Eppendorf AG (Germany), Dassault Systemes SE (France), ID Business Solutions (IDBS) Ltd. (U.K.), KineMatik Inc. (U.S.), Lab-Ally, LLC (U.S.), Labforward GmbH (Germany), Labii Inc. (U.S.), LabArchives, LLC. (U.S.), LabLynx, Inc. (U.S.), LABTrack, LLC. (U.S.), LabWare, Inc. (U.S.), Mestrelab Research, S.L. (Spain), PerkinElmer, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Waters Corporation (U.S.), among others.

Key Questions Answered in the Report:

• Which are the high-growth market segments in terms of product, technology, channel, end user, and geography?
• What was the historical market size for electronic lab notebooks in North America?
• What are the market forecasts and estimates for the period 2024–2030?
• What are the major drivers, restraints, opportunities, and challenges in the North America electronic lab notebooks market?
• Who are the major players in the North America electronic lab notebooks market?
• What is the competitive landscape like, and who are the market leaders in the North America electronic lab notebooks market?
• What are the recent developments in the North America electronic lab notebooks market?
• What are the strategies adopted by major players in the North America electronic lab notebooks market?

PURCHASE NOW : https://www.meticulousresearch.com/Checkout/81327679

Contact Us:
Meticulous Research®
Email-  sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn-  https://www.linkedin.com/company/meticulous-research

Meticulous Research®, a renowned global market research firm, recently released its latest report titled,   ‘ Dental Imaging Market   Size, Share, Forecast, & Trends Analysis By Product (Extraoral [CBCT, Cephalometric, Panoramic], Intraoral [Scanners, X-ray, Sensor, Camera], Software) Application (Implant, Prosthetic, Surgery) Portability – Global Forecast to 2031’ . This detailed report provides in-depth insights into the growing dental imaging industry.

The dental imaging market is forecast to reach $5.12 billion by 2031, experiencing a compound annual growth rate (CAGR) of 4.9% between 2024 and 2031. Several factors are driving this market growth, including the increasing prevalence of oral health issues, a growing geriatric population, and a rising demand for cosmetic dentistry. Additionally, advances in CAD/CAM dentistry and expanding dental tourism markets present significant opportunities for further growth.

Download Sample Report Here @  https://www.meticulousresearch.com/download-sample-report/cp_id=5880

Key Players in the Market

Several major companies are leading the charge in dental imaging, including Midmark Corporation (U.S.), 3Shape A/S (Denmark), and Carestream Dental LLC (U.S.). Other key players include Amann Girrbach AG (Austria), Institut Straumann AG (Switzerland), and Align Technology, Inc. (U.S.). These firms continue to introduce cutting-edge technologies that cater to the evolving needs of the dental industry.

Segmented Market Insights

The dental imaging market is categorized by product type, application, portability, and geography. One of the key product segments includes extraoral imaging systems, such as cone-beam computed tomography (CBCT) and panoramic imaging. By 2024, extraoral imaging systems are expected to capture 44.5% of the market. The high adoption rate of CBCT scanners, which offer enhanced diagnostic capabilities, plays a significant role in this segment’s success.

On the application front, orthodontics is anticipated to see the highest growth, with a CAGR of 6.3% from 2024 to 2031. The increasing popularity of clear aligners and advanced intraoral scanners is contributing to the demand in this segment. The growing focus on dental aesthetics, driven by cosmetic dentistry, further supports this trend.

Emerging Trends and Technological Advancements

Portable dental imaging systems are gaining traction due to their convenience and improved technology. This segment is expected to experience the highest growth, driven by innovations such as 3D dental light scanners. A notable development in this regard was the September 2022 launch of TRIOS 5 Wireless by 3Shape A/S, a portable intraoral scanner that simplifies digital dentistry.

Regional Outlook and Market Leaders

Geographically, North America is projected to hold the largest market share by 2024, led by the United States. The adoption of advanced dental technologies and high rates of dental health awareness contribute to this region’s dominance. The high incidence of dental conditions such as cavities and periodontal diseases in the U.S. further drives the demand for advanced dental imaging solutions.

Overall, this report provides a comprehensive analysis of the dental imaging market’s future outlook, focusing on emerging trends, key players, and potential growth opportunities.

Key Questions Answered in the Report:

• What is the current value of revenue generated by the sale of dental imaging systems across the globe?
• At what rate is the demand for dental imaging systems & software projected to grow for the next 5-7 years globally?
• What is the historical market size and growth rate for dental imaging systems & software across the globe?
• What are the major factors impacting the growth of this market at the global and regional levels? What are the major opportunities for existing market players and new entrants in the market?
• Which segments are creating major traction for the vendors in this market in terms of product, application, portability, and end user?
• What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the dental imaging market?
• Who are the major players in the dental imaging market? And what are their specific dental imaging systems & software offered in the industry?
• What recent developments have taken place in the dental imaging market, and how these strategic developments are creating a global impact in this market?

Quick Buy :   https://www.meticulousresearch.com/Checkout/91091539

Contact Us:
Meticulous Research®
Email-  sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn-  https://www.linkedin.com/company/meticulous-research

The Electronic Lab Notebook (ELN) Market is projected to achieve a growth rate of 7.1% annually, reaching $787.7 million by 2029 . The transition from traditional paper notebooks to ELNs is driven by their enhanced capabilities in data recording, sharing, and security. The increasing complexity of laboratory procedures necessitates more efficient documentation solutions, boosting laboratory automation. Key factors propelling the ELN market include increased R&D investments, technological advancements, and the need to meet stringent regulatory requirements. Moreover, the growing adoption of cloud-based platforms and the drive to reduce costs, enhance workflow efficiency, and gain valuable business insights are further encouraging the use of ELNs.

Here are the top 10 companies operating in the  Electronic Lab Notebook (ELN) Market

PerkinElmer, Inc. (U.S.)

Established in 1947 and headquartered in Waltham, Massachusetts, PerkinElmer, Inc. provides a range of products and services for diagnostics, food, environmental, industrial, and life sciences markets. The company operates through its discovery & analytical solutions and diagnostics segments, with a global reach in over 150 countries through direct and distributor channels.

Dassault Systemes SE (France)

Dassault Systemes SE, founded in 1981 and based in Velizy-Villacoublay, France, is renowned for its 3D design, digital mock-up, and product lifecycle management (PLM) software. The company offers comprehensive end-to-end solutions to support innovation and maintains a presence in Europe, the Americas, and Asia, with offices in France, Japan, and the U.S.

Waters Corporation (U.S.)

Waters Corporation, founded in 1958 and headquartered in Milford, Massachusetts, specializes in analytical science solutions that support discovery, performance, and regulatory compliance. The company operates through its Waters and TA segments and serves a global market including the U.S., Europe, Asia-Pacific, and the Middle East & Africa.

ID Business Solutions (IDBS) Ltd. (U.K.)

ID Business Solutions (IDBS) Ltd., established in 1989 and located in Surrey, U.K., provides advanced software for the secure management and sharing of research data. After its acquisition by Danaher in 2017, IDBS became part of Danaher’s Life Sciences platform. The company operates in various countries, including Germany, France, the U.K., Japan, and the U.S.

Abbott Laboratories (U.S.)

Founded in 1900 and headquartered in Chicago, Illinois, Abbott Laboratories is a major player in the global healthcare market. The company operates through four segments: established pharmaceuticals, diagnostics, nutritional products, and cardiovascular and neuromodulation. Abbott’s operations extend across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Download Sample Report Here : https://www.meticulousresearch.com/download-sample-report/cp_id=4341

Agilent Technologies, Inc. (U.S.)

Agilent Technologies, Inc., founded in 1999 and based in Santa Clara, California, provides a range of instruments, consumables, services, and solutions for life sciences, diagnostics, and chemical markets. The company operates through three segments: life sciences & applied markets, Agilent CrossLab, and diagnostics & genomics. Agilent has a global presence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Thermo Fisher Scientific Inc. (U.S.)

Thermo Fisher Scientific Inc., formed in 2006 by merging Thermo Electron and Fisher Scientific, is headquartered in Waltham, Massachusetts. The company offers a wide range of analytical instruments, reagents, consumables, and software through its brands, including Thermo Scientific and Applied Biosystems. Thermo Fisher operates across four segments: life sciences solutions, analytical instruments, laboratory products & services, and specialty services. The company has a global footprint, including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Bio-ITech BV (the Netherlands)

Bio-ITech BV, located in the Netherlands, focuses on providing software solutions for managing laboratory information, including web-based electronic laboratory notebooks (ELNs) that ensure compliance with GLP standards. The company operates in North America and Europe.

KineMatik Inc. (U.S.)

KineMatik Inc., established in 1999 and based in Illinois, U.S., develops laboratory informatics software designed to improve efficiency and facilitate knowledge sharing. As an OpenText technology partner, KineMatik offers solutions for the OpenText Content Suite/xECM. The company’s ELN solutions support data capture, global collaboration, and regulatory compliance.

LabWare, Inc. (U.S.)

LabWare, Inc., founded in 1987 and headquartered in Wilmington, Delaware, is a leading provider of integrated laboratory informatics solutions. The company’s Enterprise Laboratory Platform includes LabWare LIMS and LabWare ELN. LabWare’s global operations span North America, Europe, the Middle East, Asia-Pacific, Africa, and Latin America, with regional offices in the U.K., Australia, Brazil, and South Africa.

Popular Mentions:

• Arxspan, LLC (U.S.)
• Benchling, Inc. (U.S.)
• Lab-Ally, LLC (U.S.)
• Labfolder GmbH (Germany)
• Labii Inc. (U.S.)
• LabArchives, LLC (U.S.)
• LabLynx, Inc. (U.S.)
• LABTrack, LLC (U.S.)
• LabVantage Solutions, Inc. (U.S.)
• Mestrelab Research, S.L. (Spain)
• RURO, Inc. (U.S.)
• SciNote, LLC (U.S.)
• SEQOME Limited (Ireland).

PURCHASE NOW : https://www.meticulousresearch.com/Checkout/12121533

Contact Us:
Meticulous Research®
Email-  sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn-  https://www.linkedin.com/company/meticulous-research

A Detailed Look at the Dental Imaging Market and Its Future

Meticulous Research® has unveiled a new report titled, ‘ ‘Dental Imaging Market Size, Share, Forecast, & Trends Analysis By Product (Extraoral [CBCT, Cephalometric, Panoramic], Intraoral [Scanners, X-ray, Sensor, Camera], Software) Application (Implant, Prosthetic, Surgery) Portability – Global Forecast to 2031,’ which forecasts significant growth in the dental imaging market. The market is expected to reach $5.12 billion by 2031, growing at a CAGR of 4.9% from 2024 to 2031. This growth is driven by the increasing prevalence of oral diseases, the high incidence of tooth loss, the growing demand for cosmetic dentistry, and a rising geriatric population. Additionally, the rise of CAD/CAM technologies and the expansion of dental tourism are expected to create substantial growth opportunities.

Segmentation by Product

The market is segmented into extraoral imaging systems, intraoral imaging systems, and software. The extraoral imaging systems segment is expected to capture the largest share, driven by the increasing adoption of CBCT scanners and the high prevalence of complex dental procedures.

Growth in Orthodontics

The orthodontics segment is expected to grow at the fastest rate, with a CAGR of 6.3% during the forecast period. This growth is driven by the increasing use of intraoral scanners and the rising popularity of clear aligners .

Portability Trends

The portable imaging systems segment is expected to witness the highest growth, thanks to technological advancements that make these systems more accessible and user-friendly. The growing focus on patient-centric care is also driving demand for portable systems.

Regional Insights

North America, particularly the U.S. , is expected to lead the global dental imaging market, driven by the high incidence of dental conditions and the widespread adoption of advanced imaging technologies.

Key Players

The key players operating in the dental imaging market are Midmark Corporation (U.S.), 3Shape A/S (Denmark), Amann Girrbach AG (Austria), Carestream Dental LLC (U.S.), Condor Technologies NV (Belgium), Envista Holdings Corporation (U.S.), Kulzer GmbH (Germany), Institut Straumann AG (Switzerland), densys Ltd. (Israel), Align Technology, Inc. (U.S.), Medit Corp. (Republic of Korea), DENTSPLY SIRONA Inc. (U.S.), Planmeca Oy (Finland), AGE Solutions S.r.l. (Italy), Shining 3D Tech Co., Ltd. (China), J. MORITA CORP. (Japan), and ACTEON Group (U.K.).

Download Sample Report Here @  https://www.meticulousresearch.com/download-sample-report/cp_id=5880

Key Questions Answered in the Report:

• What is the current value of revenue generated by the sale of dental imaging systems across the globe?
• At what rate is the demand for dental imaging systems & software projected to grow for the next 5-7 years globally?
• What is the historical market size and growth rate for dental imaging systems & software across the globe?
• What are the major factors impacting the growth of this market at the global and regional levels? What are the major opportunities for existing market players and new entrants in the market?
• Which segments are creating major traction for the vendors in this market in terms of product, application, portability, and end user?
• What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the dental imaging market?
• Who are the major players in the dental imaging market? And what are their specific dental imaging systems & software offered in the industry?
• What recent developments have taken place in the dental imaging market, and how these strategic developments are creating a global impact in this market?

Contact Us:
Meticulous Research®
Email-  sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn-  https://www.linkedin.com/company/meticulous-research

Meticulous Research®, a prominent market research company, has released a report titled " Next Generation Sequencing (NGS) Informatics Market by Offering (Data Analysis, Interpretation & Reporting, Storage & Computing, LIMS), Application (Diagnostic, Drug Discovery, Precision Medicine, Biomarker Discovery) End User - Global Forecast to 2030." This report forecasts that the NGS informatics market will reach $4.3 billion by 2030, with a CAGR of 15.4% during the forecast period.

The market's growth is driven by increasing R&D investments by pharmaceutical and biotechnology firms, rising cancer and genetic disorder rates, growing NGS use in diagnostics and precision medicine, technological advancements, and government support for large-scale genomic projects. However, data confidentiality concerns are a growth barrier.

The expanding use of NGS informatics tools in hospitals and clinical labs and the increasing adoption of bioinformatics and genomic data management solutions for large-scale data analysis are expected to create growth opportunities. However, a significant challenge is the shortage of skilled professionals to operate NGS informatics tools.

Next Generation Sequencing (NGS) Informatics Market: Future Outlook

The NGS informatics market is segmented by Offering (Software [Data Analysis Software, Data Interpretation and Reporting Tools, Data Storage and Computing Tools, Laboratory Information Management Systems {LIMS}], Deployment Mode [Web and Cloud-based, On-premise], NGS Informatics Services); Application (Disease Diagnoses, Biomarker Discovery, Drug Discovery, Precision Medicine, Agriculture and Animal Research); End User (Pharmaceutical & Biotechnology Companies, Hospitals and Diagnostic Laboratories, Academic & Research Institutes, Other End Users); and Geography. The report also evaluates industry competitors and provides regional and country-level market analysis.

Offering Insights

In 2023, the software segment is expected to hold the largest share of the NGS informatics market due to software's ability to process, store, and share large volumes of NGS and genomic data efficiently and securely, and the growing need for scalable genomic data storage.

Application Insights

The market includes disease diagnoses, biomarker discovery, drug discovery, precision medicine, agriculture, and animal research. The drug discovery segment is projected to dominate in 2023, driven by the decreasing cost of sequencing, the capability of NGS informatics to detect genetic mutations, and increased R&D spending for new drug discovery.

End User Insights

The NGS informatics market is segmented into pharmaceutical & biotechnology companies, hospitals and diagnostic laboratories, academic & research institutes, and other end users. Pharmaceutical & biotechnology companies are expected to lead the market in 2023 due to increased sequencing information use, high R&D activities, rising outsourcing of R&D projects, and decreasing sequencing costs.

Geographic Analysis

The report covers North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America is expected to dominate the NGS informatics market in 2023, followed by Europe and Asia-Pacific. The U.S. is anticipated to be the largest market in North America, driven by high R&D expenditure, the presence of key market players, supportive government initiatives, extensive NGS-based research applications, and favorable reimbursement scenarios for NGS tests.

Key Players

The key players operating in the next generation sequencing (NGS) informatics market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Qiagen N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Sapio Sciences, LLC (U.S.), DNASTAR, Inc. (U.S.), Fabric Genomics, Inc. (U.S.), Partek Incorporated (U.S.), and DNAnexus, Inc. (U.S.).

Download Sample Report Here @  https://www.meticulousresearch.com/download-sample-report/cp_id=3483

Key questions answered in the report:

• Which are the high-growth market segments in terms of offering, application, end user, and region/country?
• What was the historical market size for next generation sequencing (NGS) informatics across the globe?
• What are the market forecasts and estimates for the period 2023–2030?
• What are the major drivers, restraints, challenges, and opportunities in the global next generation sequencing (NGS) informatics market?
• Who are the major players in the global next generation sequencing (NGS) informatics market?
• How is the competitive landscape, and who are the market leaders in the global next generation sequencing (NGS) informatics market?
• What are the recent developments in the next generation sequencing (NGS) informatics market?
• What are the different strategies adopted by the major players in the next generation sequencing (NGS) informatics market?
• What are the geographical trends and high growth regions/countries?

Contact Us:
Meticulous Research®
Email-  sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn-  https://www.linkedin.com/company/meticulous-research